Emergent Biosolutions, Inc. (EBS) financial statements (2020 and earlier)

Company profile

Business Address 400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG, MD 20879
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments139112178272313280179
Cash and cash equivalents139112178272313280179
Restricted cash and investments001    
Receivables2812711461481276061
Inventory, net of allowances, customer advances and progress billings23020614374776615
Inventory23020614374776615
Deferred costs271     
Income taxes receivable6
Other undisclosed current assets22301716222613
Total current assets:700621485510539432273
Noncurrent Assets
Property, plant and equipment529510407376332314264
Intangible assets, net (including goodwill)9961,0211697511210044
Goodwill2692604941554214
Intangible assets, net (excluding goodwill)72876212034575830
Other noncurrent assets671462783
Other undisclosed noncurrent assets416336549142
Total noncurrent assets:1,6341,609585460505513354
TOTAL ASSETS:2,3342,2291,0709701,044945627
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1991748476877953
Accounts payable91814235464128
Accrued liabilities523156661
Employee-related liabilities56583835353225
Taxes payable 5     
Debt1010 20   
Business combination, contingent consideration, liability56     
Deferred revenue and credits137852
Contract with customer, liability11
Other liabilities11      
Other undisclosed current liabilities 623591
Total current liabilities:2752001001061009357
Noncurrent Liabilities
Long-term debt and lease obligation8137851324825325162
Long-term debt, excluding current maturities8137851324825325162
Liabilities, other than long-term debt1491793410872
Deferred revenue and credits17876 
Accounts payable and accrued liabilities 1113    
Contract with customer, liability8263
Deferred tax liabilities, net68     
Other liabilities533852112
Business combination, contingent consideration, liability15     
Other undisclosed noncurrent liabilities61541010234117
Total noncurrent liabilities:1,0241,0185826828429981
Total liabilities:1,2991,219158374384392137
Stockholders' equity
Stockholders' equity attributable to parent1,0351,011912596660553490
Common stock0000000
Treasury stock, value(40)(40)(39)(6)(6)(6)(6)
Additional paid in capital709689618352318274248
Accumulated other comprehensive loss(9)(6)(4)(4)(3)(3)(3)
Retained earnings375367337254351288252
Stockholders' equity attributable to noncontrolling interest      (0)
Total stockholders' equity:1,0351,011912596660553489
TOTAL LIABILITIES AND EQUITY:2,3342,2291,0709701,044945627

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1,016782561489523450313
Revenue, net561489523450313
Cost of revenue
(Cost of Goods and Services Sold)
(402)(322)(196)(131)(124)(118)(62)
Gross profit:614460365357398332251
Operating expenses(496) (241)(252)(302)(298)(212)
Other undisclosed operating income (loss)(70)(370)   244
Operating income:4890124106965843
Nonoperating income (expense)(38)(8)(6)(6)(6)(5)1
Investment income, nonoperating  21100
Other nonoperating income (expense)(1)2(1)0(0)30
Interest and debt expense(37)(10)(7)(8)(7)(8) 
Other undisclosed income from continuing operations before equity method investments, income taxes37107878 
Income from continuing operations before income taxes:108211999905343
Income tax expense(5)(19)(36)(37)(27)(16)(13)
Income from continuing operations:4638363633730
Loss from discontinued operations   (11)   
Net income:4638352633730
Net income attributable to noncontrolling interest      1
Net income available to common stockholders, basic:4638352633731
Interest on convertible debt   333 
Net income available to common stockholders, diluted:4638355664031

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:4638352633730
Other comprehensive loss(4)(2)     
Other undisclosed comprehensive income (loss)(1) 1(2)002
Comprehensive income (loss):(0)618350633732
Comprehensive loss, net of tax, attributable to noncontrolling interest      (1)
Comprehensive income (loss), net of tax, attributable to parent:(0)618350633731

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: